Skip to main content
Published locations for FDA: No excess mortality risk from paclitaxel stents, balloons for peripheral intervention
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA: No excess mortality risk from paclitaxel stents, balloons for peripheral intervention
User login
Username
Password
Reset your password
/content/fda-no-excess-mortality-risk-paclitaxel-stents-balloons-peripheral-intervention
/ecardiologynews/article/264067/interventional-cardiology-surgery/fda-no-excess-mortality-risk
/cardiology/article/264067/interventional-cardiology-surgery/fda-no-excess-mortality-risk-paclitaxel